select study semaglutide SELECT: Semaglutide's Impact on CVD Events Emerges Quickly The SELECT Trial - A
Description
In response to Hims & Hers Superbowl ad, Novo Nordisk placed an ad titled, Check Before You Inject, the next day in the New York Times and US Today warning consumers about the significant dangers of illegitimate compounded 'semaglutide drugs, which have been shown to contain impurities, ingredients dangerous to patients, and incorrect dosages

It is important to note that real-world results from these therapies often differ from the results from controlled clinical trials

Integrating Compounded Semaglutide into Lymphedema Care PlexusDx offers compounded semaglutide injection from licensed 503A pharmacies, ensuring pharmaceutical-grade purity and consistency without the insurance gatekeeping that blocks many patients from accessing GLP-1 therapy

Given below is the typical dosing schedule: Weeks 14 : 0.25 mg once weekly (initial dose) Weeks 58 : 0.5 mg once weekly Weeks 912 : 1 mg once weekly Weeks 1316 : 1.7 mg once weekly Week 17 and onward : 2.4 mg once weekly (maintenance dose for adults and pediatric patients aged 12 years and older) Each dose is administered subcutaneously using a prefilled injection pen

[170] Healthcare providers should regularly reassess the need for continued treatment and consider periodic drug holidays to evaluate ongoing necessity
